Pancreatic Cancer Research

ResearcherEuromedicaActive in the last 2 years

Antonios-Apostolos K. Tentes

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-8936-6679; OpenAlex author ID A5009351806. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers

Papers 7

  1. Pancreatic cancer with synchronous peritoneal and hepatic metastases: A case report. Co-author DOI 10.1016/j.ijscr.2024.109588↗
  2. Resectable Pancreatic Cancer With Peritoneal Metastases: Is Cytoreduction Combined With Hipec Effective and When? Co-author DOI 10.32388/olbfry↗
  3. Hyperthermic intra-operative intraperitoneal chemotherapy as an adjuvant to pancreatic cancer resection. Co-author DOI 10.21037/jgo-20-46↗
  4. Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer. Co-author PMID 29745096↗
  5. The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer. Co-author DOI 10.1080/02656736.2016.1227094↗
  6. Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study. Co-author DOI 10.1007/s00280-011-1717-6↗
  7. Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer. Co-author DOI 10.1155/2012/506571↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nicolaos Courcoutsakis · 2 shared papers, 2012–2024 · strength 0.34
  2. Anastasia Fotiadou · 1 shared paper, 2024 · strength 0.28
  3. Christos Hristakis · 2 shared papers, 2016–2018 · strength 0.18
  4. Stylianos Kakolyris · 2 shared papers, 2012 · strength 0.06
  5. Panos Prasopoulos · 1 shared paper, 2012 · strength 0.03
  6. Nikolaos Xenidis · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.